Vaxil Bio Ltd VXLLF

Primary Symbol: V.VXL

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron May 19, 2021 7:23am

98 Views

Post# 33228388

market depth looking a little better

pecial terms and non-boardlot orders do not appear in Depth by Price +Vertical +Columnar +Horizontal

V:VXL Depth by Order @03:29:07

Bid			Ask
Broker	Size	Price	Price	Size	Broker
7 TD Sec	20,000	0.09	0.095	5,000	68 Leede
7 TD Sec	20,000	0.09	0.095	10,000	80 National Bank
7 TD Sec	20,000	0.09	0.105	11,000	79 CIBC
68 Leede	9,000	0.085	0.105	15,500	80 National Bank
9 BMO Nesbitt	30,000	0.085	0.105	17,500	80 National Bank
80 National Bank	22,000	0.085	0.105	20,000	7 TD Sec
80 National Bank	30,000	0.085	0.105	7,000	7 TD Sec
80 National Bank	2,000	0.085	0.11	10,000	85 Scotia
7 TD Sec	30,000	0.085	0.11	1,500	80 National Bank
68 Leede	10,000	0.08	0.11	2,000	80 National Bank